C000198378 Fees and Costs — iShares Evolved U.S. Innovative Healthcare ETF
Data updated: 2022-10-12
The net expense ratio is 0.18%. There are no sales loads or redemption fees. In fiscal 2022 the fund paid $1K in broker commissions, 0.0026% of average net assets, and portfolio turnover was 6%.
C000198378 Fees and Expenses
Annual operating expenses and sales charges of C000198378. Prospectus, as of November 30, 2021.
| Annual operating expenses | |
|---|---|
| Management fee | 0.18% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.00% |
| Gross expense ratio | 0.18% |
| Fee waiver | — |
| Net expense ratio | 0.18% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | No |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
C000198378 Costs Over Time
On $10,000 invested in C000198378, assuming 5% a year before costs, total costs come to $116 over 5 years, cutting the return by 0.19% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.18%) | $19 | $59 | $104 |
| Trading costs (broker commissions) | $0 | $1 | $2 |
| Lost growth on money paid in costs | $0 | $3 | $11 |
| Total costs | $19 | $63 | $116 |
| Value after costs | $10,481 | $11,513 | $12,647 |
| Impact on return, per year | 0.19% | 0.19% | 0.19% |
C000198378 Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending July 31, 2022.
- Explicit cost rate (commissions ÷ average net assets): 0.0026%
- Total broker commissions: $1K
- Bought from dealers (principal trades, not a cost): $25.8M
- Portfolio turnover (prospectus): 6%
- Securities on loan, average value: $407K
- Net income from securities lending: $5K (0.013% of average net assets)
C000198378 Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Morgan Stanley & Co. LLC | $573 | 56.74% |
| Citigroup Global Markets Inc. | $300 | 29.70% |
| Jefferies LLC | $69 | 6.83% |
| UBS Securities LLC | $61 | 6.05% |
| Credit Suisse Securities (USA) LLC | $7 | 0.67% |
C000198378 Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| National Securities Clearing Corporation | $19.8M | 78.07% |
| BlackRock Funds III - BlackRock Cash Funds: Treasury | $5.6M | 21.93% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.